¨ Brattstro¨m, L., Wilcken, D. E. L., Ohrvik, J. et al. Common
methylenetetrahydrofolate reductase gene mutation leads to
hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation, 98:2520–2526, Dec. 1998.
Fruchart, J. C., Nierman, M. C., Stroes, E. S. G., Kastelein, J. J. P., Duriez, P. et al. New risk factors for atherosclerosis and patient risk assessment. Circulation, 109:III-15–III-19, Jun. 2004.
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., Stehouwer, C. D. A. et al. Hyperhomocysteinemia increases risk of death, especially in type II Diabetes: 5-Year follow-up of the Hoorn study. Circulation, 101:1506–1511, Apr. 2000.
Lange, H., Suryapranata, H., De Luca, G. et al. Folate therapy and in-stent restenosis after coronary stenting. N. Engl. J. Med., 350: 2673–2681, 2004.
Pullin, C. H., Ashfield-Watt, P. A. L., Burr, M. L. et al. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype. J. Am. Coll. Cardiol., 58:1799–805, 2001.

Страницы: 1 | 2 | 3